Zeev's Turnips Patch-No Politics (ZEEV)

[Zeev Hed]

Yes, I am still in NOVN, but I would not be surprised to see it revisit the sub $10 area, where I plan to double up. The reason for the market's reaction is that the impact of Wyeth's problems with HTR are indeed showing up in NOVN's sales, the company was telling everyone that Wyeth's problems should be their benefit, it turns out that there is fear in the market place related to HTR, wether transdermal or oral. The rational for the difference was that no "liver" processing occur in transdermal delivery, unlike oral delivery and thus side effects associated with oral delivery would not be present. In the absence of a clinical study which shows the benefit of transdermal delivery, NOVN will have to rely on other patches.

Zeev